Collaborations COLLABORATIONS CiMaas has a close collaboration with several partners. Brightlands UM Holding Maastricht Kiadis Pharma Miltenyi Alcami BasicPharma Neuroplast AmpTec InSciTe Biomedical Latest news CiMaas featured in Brightlands media campaign June 21, 2019 CiMaas obtains gene therapy classification from EMA for its’ DC vaccine June 20, 2019 CiMaas to collaborate with Kiadis on NK cell development after Cytosen acquisition June 7, 2019 CiMaas to present at BIO Capital Europe 2019 in Amsterdam March 1, 2019 CiMaas receives ATMP classification from EMA for NK cell product February 24, 2019
